These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4941068)

  • 1. New patterns of immunoglobulin deposition in the lesions of malignant nephrosclerosis, with special reference to IgE.
    Gerber MA; Paronetto F
    Am J Pathol; 1971 Dec; 65(3):535-42. PubMed ID: 4941068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaline arteriolar nephrosclerosis. Immunofluorescence findings in the vascular lesions.
    Valenzuela R; Gogate PA; Deodhar SD; Gifford RW
    Lab Invest; 1980 Dec; 43(6):530-4. PubMed ID: 7003256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal vascular lesions in severe hypertension. Transitional changes from benign to malignant nephrosclerosis.
    Akikusa B; Kondo Y; Irabu N; Shigematsu H
    Acta Pathol Jpn; 1983 Mar; 33(2):323-31. PubMed ID: 6869004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
    Velosa J; Miller K; Michael AF
    Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant nephrosclerosis.
    Burkholder PM
    Arch Pathol; 1965 Dec; 80(6):583-9. PubMed ID: 4159228
    [No Abstract]   [Full Text] [Related]  

  • 6. IMMUNOCYTOCHEMICAL OBSERVATIONS ON THE VASCULAR NECROSIS AND RENAL GLOMERULAR LESIONS OF MALIGNANT NEPHROSCLEROSIS.
    PARONETTO F
    Am J Pathol; 1965 Jun; 46(6):901-15. PubMed ID: 14328020
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Three-dimensional morphologic examination of normal and diseased renal arterioles].
    Rázga Z
    Orv Hetil; 2003 Nov; 144(44):2165-72. PubMed ID: 14686064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decompensated benign nephrosclerosis and secondary malignant nephrosclerosis.
    Ratschek M; Ratschek E; Bohle A
    Clin Nephrol; 1986 May; 25(5):221-6. PubMed ID: 3720032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular arteriolar nodules. Their presence in heart, pancreas, and kidneys of patients with malignant nephrosclerosis.
    Hughson MD; Harley RA; Henninger GR
    Arch Pathol Lab Med; 1982 Feb; 106(2):71-4. PubMed ID: 6895829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arteriolar nephrosclerosis in the Syrian hamster.
    Slauson DO; Hobbs CH; Crain C
    Vet Pathol; 1978 Jan; 15(1):1-11. PubMed ID: 625859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between thrombotic microangiopathy and activated alternative complement pathway in malignant nephrosclerosis.
    Zhang Y; Yang C; Zhou X; Hu R; Quan S; Zhou Y; Li Y; Xing G
    Nephrol Dial Transplant; 2020 Dec; ():. PubMed ID: 33367879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of immune reactions which are localized in the vessel wall in patients with malignant nephrosclerosis].
    Schäfer HE; Schäfer A
    Munch Med Wochenschr; 1968 Oct; 110(42):2424-7. PubMed ID: 4881841
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB; Tarantino A; Bazzi C; Colasanti G; Guerra L; Durante A
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria in benign nephrosclerosis.
    Morduchowicz G; Boner G; Ben-Bassat M; Rosenfeld JB
    Arch Intern Med; 1986 Aug; 146(8):1513-6. PubMed ID: 3729631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morpho- and pathogenesis of nephrosclerosis: a clinico-morphological analysis].
    Serov VV; Iargin SV
    Ter Arkh; 1986; 58(8):4-9. PubMed ID: 3532411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation.
    Wang Z; Zhang Z; Li Y; Zhang Y; Wei M; Li H; Yang S; Zhou Y; Zhou X; Xing G
    Hypertens Res; 2023 Jul; 46(7):1759-1770. PubMed ID: 37188751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events.
    Sechi LA; Zingaro L; Catena C; De Marchi S
    Thromb Haemost; 2000 Oct; 84(4):565-70. PubMed ID: 11057851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of malignant nephrosclerosis with special reference to the difference between histologic manifestations of pure and exacerbated forms.
    Fujimoto T
    Tohoku J Exp Med; 1978 Jun; 125(2):135-53. PubMed ID: 694919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant nephrosclerosis during pregnancy and in the postpartum period (the uremic hemolytic syndrome).
    Beller FK; Intorp HW; Losse H; Loew H; Moenninghoff W; Schmidt EH; Grundmann E
    Am J Obstet Gynecol; 1976 Jul; 125(5):633-9. PubMed ID: 779474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.